18 Nov 2024
// ACCESSWIRE
https://www.accesswire.com/943498/prcabtreotm-clindamycin-phosphate-adapalene-and-benzoyl-peroxide-gel-treatment-for-acne-vulgaris-receives-positive-reimbursement-recommendations-from-canadas-drug-agency-and-quebecs-inesss
11 Sep 2024
// ACCESSWIRE
https://www.accesswire.com/915793/health-canada-approves-prcabtreotm-clindamycin-phosphate-adapalene-and-benzoyl-peroxide-triple-combination-topical-treatment-for-acne-vulgaris-in-patients-12-years-of-age-and-older
20 May 2024
// PHARMIWEB
https://www.pharmiweb.com/press-release/2024-05-20/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne
16 May 2024
// PHARRMIWEB
https://www.pharmiweb.com/press-release/2024-05-16/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne
28 Feb 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf
20 Oct 2023
// ACCESSWIRE